HL7 FHIR® Implementation Guide: Electronic Case Reporting (eCR) - US Realm
2.1.1 - STU 2.1.1 United States of America flag

This page is part of the electronic Case Reporting (eCR) (v2.1.1: STU 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in it's permanent location. For a full list of available versions, see the Directory of published versions

: Example ValueSet: Medications Triggers for Public Health Reporting - JSON Representation

Active as of 2018-08-01

Raw json | Download


{
  "resourceType" : "ValueSet",
  "id" : "valueset-mrtc-example",
  "meta" : {
    "profile" : [
      🔗 "http://hl7.org/fhir/us/ecr/StructureDefinition/us-ph-triggering-valueset"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"http://www.nlm.nih.gov/research/umls/rxnorm\"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>809002</td><td>Carbidopa 10 MG / Levodopa 100 MG Disintegrating Oral Tablet [Parcopa]</td></tr><tr><td>476515</td><td>Carbidopa 25 MG / Levodopa 250 MG Disintegrating Oral Tablet</td></tr><tr><td>308988</td><td>Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet</td></tr><tr><td>724606</td><td>Carbidopa 10 MG / Levodopa 100 MG Oral Tablet [Sinemet]</td></tr><tr><td>1600914</td><td>8 HR Carbidopa 48.75 MG / Levodopa 195 MG Extended Release Oral Capsule</td></tr><tr><td>476399</td><td>Carbidopa 25 MG / Levodopa 100 MG Disintegrating Oral Tablet</td></tr></table></li></ul></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-steward",
      "valueContactDetail" : {
        "name" : "CSTE Steward"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "CSTE Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode" : "pher"
    }
  ],
  "url" : "http://hl7.org/fhir/us/ecr/ValueSet/valueset-mrtc-example",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1146.1060"
    }
  ],
  "version" : "2.1.1",
  "name" : "Example_Medications_Triggers_for_Public_Health_Reporting",
  "title" : "Example Medications Triggers for Public Health Reporting",
  "status" : "active",
  "experimental" : true,
  "date" : "2018-08-01",
  "publisher" : "HL7 International / Public Health",
  "contact" : [
    {
      "name" : "HL7 International / Public Health",
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://www.hl7.org/Special/committees/pher"
        }
      ]
    }
  ],
  "description" : "This example set of values contains CVX, RXNORM,and SNOMED medication codes that may represent that the patient may have a potentially reportable condition. These pertain to medications administered and medications prescribed, where the medication, coded in CVX,RXNORM,SNOMED, may be indicative of a reportable condition.",
  "useContext" : [
    {
      "code" : {
        "system" : "http://hl7.org/fhir/us/ecr/CodeSystem/us-ph-usage-context-type",
        "code" : "reporting",
        "display" : "Reporting"
      },
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "http://hl7.org/fhir/us/ecr/CodeSystem/us-ph-usage-context",
            "code" : "triggering",
            "display" : "Triggering"
          }
        ]
      }
    },
    {
      "code" : {
        "system" : "http://hl7.org/fhir/us/ecr/CodeSystem/us-ph-usage-context-type",
        "code" : "priority",
        "display" : "Priority"
      },
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "http://hl7.org/fhir/us/ecr/CodeSystem/us-ph-usage-context",
            "code" : "routine",
            "display" : "Routine"
          }
        ]
      }
    }
  ],
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US",
          "display" : "United States of America"
        }
      ],
      "text" : "United States of America"
    }
  ],
  "purpose" : "Prescription drugs names used in observations documented in a clinical record.",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "809002",
            "display" : "Carbidopa 10 MG / Levodopa 100 MG Disintegrating Oral Tablet [Parcopa]"
          },
          {
            "code" : "476515",
            "display" : "Carbidopa 25 MG / Levodopa 250 MG Disintegrating Oral Tablet"
          },
          {
            "code" : "308988",
            "display" : "Carbidopa 25 MG / Levodopa 100 MG Extended Release Oral Tablet"
          },
          {
            "code" : "724606",
            "display" : "Carbidopa 10 MG / Levodopa 100 MG Oral Tablet [Sinemet]"
          },
          {
            "code" : "1600914",
            "display" : "8 HR Carbidopa 48.75 MG / Levodopa 195 MG Extended Release Oral Capsule"
          },
          {
            "code" : "476399",
            "display" : "Carbidopa 25 MG / Levodopa 100 MG Disintegrating Oral Tablet"
          }
        ]
      }
    ]
  }
}